Drug Shortage Report for MYLAN-AMIODARONE
| Report ID | 4090 |
| Drug Identification Number | 02240604 |
| Brand name | MYLAN-AMIODARONE |
| Common or Proper name | Amiodarone |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | AMIODARONE HYDROCHLORIDE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100BT |
| ATC code | C01BD |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2017-06-04 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2017-05-01 |
| Shortage status | Avoided shortage |
| Updated date | 2017-05-04 |
| Company comments | Duplicate report. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2017-05-04 | French | Compare |
| v4 | 2017-05-04 | English | Compare |
| v3 | 2017-05-04 | English | Compare |
| v2 | 2017-03-23 | French | Compare |
| v1 | 2017-03-23 | English | Compare |
Showing 1 to 5 of 5